Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia

We explored the feasibility of collecting convalescent plasma for passive immunotherapy of Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using ELISA to screen serum samples from 443 potential plasma donors: 196 patients with suspected or laboratory-confirmed MERS-CoV infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Arabi, Yaseen M., Hajeer, Ali H., Luke, Thomas, Raviprakash, Kanakatte, Balkhy, Hanan, Johani, Sameera, Al-Dawood, Abdulaziz, Al-Qahtani, Saad, Al-Omari, Awad, Al-Hameed, Fahad, Hayden, Frederick G., Fowler, Robert, Bouchama, Abderrezak, Shindo, Nahoko, Al-Khairy, Khalid, Carson, Gail, Taha, Yusri, Sadat, Musharaf, Alahmadi, Mashail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994343/
https://www.ncbi.nlm.nih.gov/pubmed/27532807
http://dx.doi.org/10.3201/eid2209.151164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994343/
https://www.ncbi.nlm.nih.gov/pubmed/27532807
http://dx.doi.org/10.3201/eid2209.151164

Ejemplares similares